Company Filing History:
Years Active: 2013-2014
Title: Inventor Spotlight: R Patrick Abergel
Introduction
R Patrick Abergel, based in Santa Monica, CA, has made significant contributions to the field of pharmaceutical delivery systems. With a total of two patents to his name, Abergel is recognized for his innovative approach in developing multifunctional applicators for ascorbic acid delivery.
Latest Patents
Among his latest inventions is a patented **Multiple-Compartment Applicator**, which comprises a dual-compartment system designed for the effective delivery of ascorbic acid. The first compartment is impermeable to oxygen and ultraviolet light, housing a solid vitamin-containing composition. The second compartment, which is liquid impermeable, contains a pharmaceutically acceptable carrier system. This ingenious design allows for the combination of the contents from both compartments just prior to use, ensuring optimal effectiveness for patients.
Additionally, Abergel has developed a **Multi-Functional Applicator** that provides stable storage for solid ascorbic acid while facilitating its topical application in solution. This applicator features an absorbent end for application and an abrasive end, enhancing user experience and effectiveness.
Career Highlights
Throughout his career, R Patrick Abergel has collaborated with reputable companies in the field, including Laboratoire Naturel Paris and Sonovia Holdings. His work in these organizations has furthered advancements in the domain of innovative pharmaceutical products.
Collaborations
Abergel has worked alongside notable professionals in his field, including his coworker, John C Castel. Their joint efforts have contributed to refining existing applications and developing new technologies in the realm of ascorbic acid delivery systems.
Conclusion
R Patrick Abergel's contributions to innovations in pharmaceutical applicators position him as a notable inventor in his field. His dedication to enhancing drug delivery methods through inventive approaches ensures that he remains a key figure in ongoing research and development.